Results for tag: "Mirabegron"

Mirabegron is a drug used to treat urological disorders, such as overactive bladder (OAB). It is a beta-3 adrenergic agonist, which works by stimulating the bladder muscles to relax and increase the capacity of the bladder. This helps to reduce the frequency of urination and improve bladder control. Mirabegron is available in both oral and injectable forms, and is typically prescribed for adults with OAB who have not responded to other treatments. Mirabegron is a relatively new drug, having been approved by the US Food and Drug Administration in 2012. It has become a popular treatment option for OAB, as it is generally well-tolerated and has fewer side effects than other medications. Some companies in the Mirabegron market include Astellas Pharma, Inc., Allergan, Inc., and Mylan N.V. Show Less Read more